Novel cationic lipids with enhanced gene delivery and antimicrobial activity

Molecular Pharmacology

Volumn 78, Issue 3, 2010, Pages 402-410

  Fein, David E ^a   Bucki, Robert ^b   Byfield, Fitzroy ^b   Leszczynska, Katarzyna ^c   Janmey, Paul A ^b   Diamond, Scott L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DEXAMETHASONE SPERMINE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DISUBSTITUTED SPERMINE; DNA; INTERLEUKIN 8; LIPOPLEX; LIPOPOLYSACCHARIDE; LIPOSOME; SPERMINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CATION; DIOLEOYL PHOSPHATIDYLETHANOLAMINE; LIPID; PHOSPHATIDYLETHANOLAMINE;

ANIMAL CELL; ARTICLE; BACILLUS SUBTILIS; BACTERICIDAL ACTIVITY; CATTLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG FORMULATION; DRUG STRUCTURE; ENDOTHELIUM CELL; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC TRANSFECTION; HEMOLYSIS; HUMAN; HUMAN CELL; LIPOSOMAL GENE DELIVERY SYSTEM; LUNG LAVAGE; NEUTROPHIL; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REPORTER GENE; TRANSGENE; ZETA POTENTIAL; ANIMAL; BOVINAE; CYSTIC FIBROSIS; EUKARYOTE; GENE THERAPY; GENE TRANSFER; GENETICS; METABOLISM; PLASMID; PROCEDURES;

ANIMALS; ANTI-INFECTIVE AGENTS; CATIONS; CATTLE; CYSTIC FIBROSIS; DEXAMETHASONE; DNA; EUKARYOTA; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; INTERLEUKIN-8; LIPIDS; PHOSPHATIDYLETHANOLAMINES; PLASMIDS; SPERMINE; TRANSFECTION; TRANSGENES;

EID: 77956258442     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.066670     Document Type: Article

References (35)

1. Aissaoui A, Martin B, Kan E, Oudrhiri N, Hauchecorne M, Vigneron JP, Lehn JM, and Lehn P (2004) Novel cationic lipids incorporating an acid-sensitive acylhydrazone linker: synthesis and transfection properties. J Med Chem 47:5210-5223.
2. Baatz JE, Zou Y, and Korfhagen TR (2001) Inhibitory effects of tumor necrosis factor-alpha on cationic lipid-mediated gene delivery to airway cells in vitro. Biochim Biophys Acta 1535:100-109.
3. Bajaj A, Kondaiah P, and Bhattacharya S (2008) Effect of the nature of the spacer on gene transfer efficacies of novel thiocholesterol derived gemini lipids in different cell lines: a structure-activity investigation. J Med Chem 51:2533-2540.
4. Bastonero S, Gargouri M, Ortiou S, Guéant JL, and Merten MD (2005) Inhibition by TNF-alpha and IL-4 of cationic lipid mediated gene transfer in cystic fibrosis tracheal gland cells. J Gene Med 7:1439-1449.
5. Behr JP, Demeneix B, Loeffler JP, and Perez-Mutul J (1989) Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc Natl Acad Sci USA 86:6982-6986.
6. Blagbrough IS, Geall AJ, and Neal AP (2003) Polyamines and novel polyamine conjugates interact with DNA in ways that can be exploited in non-viral gene therapy. Biochem Soc Trans 31:397-406.
7. Boucher RC (2007) Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev Med 58:157-170.
8. Bucki R, Byfield FJ, Kulakowska A, McCormick ME, Drozdowski W, Namiot Z, Hartung T, and Janmey PA (2008) Extracellular gelsolin binds lipoteichoic acid and modulates cellular response to proinflammatory bacterial wall components. J Immunol 181:4936-4944.
9. Bucki R and Janmey PA (2006) Interaction of the gelsolin-derived antibacterial PBP 10 peptide with lipid bilayers and cell membranes. Antimicrob Agents Chemother 50:2932-2940.
10. Bucki R, Sostarecz AG, Byfield FJ, Savage PB, and Janmey PA (2007) Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum. J Antimicrob Chemother 60:535-545.
11. Caracciolo G, Pozzi D, Caminiti R, Marchini C, Montani M, Amici A, and Amenitsch H (2007) Transfection efficiency boost by designer multicomponent lipoplexes. Biochim Biophys Acta 1768:2280-2292.
12. Chin JN, Rybak MJ, Cheung CM, and Savage PB (2007) Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus. Antimicrob Agents Chemother 51:1268-1273.
13. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, and Danielsen M (1987) Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84:7413-7417.
14. Gao X and Huang L (1991) A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem Biophys Res Commun 179:280-285.
15. Gruneich JA, Price A, Zhu J, and Diamond SL (2004) Cationic corticosteroid for nonviral gene delivery. Gene Ther 11:668-674.
16. Heyes JA, Niculescu-Duvaz D, Cooper RG, and Springer CJ (2002) Synthesis of novel cationic lipids: effect of structural modification on the efficiency of gene transfer. J Med Chem 45:99-114.
17. Hirko A, Tang F, and Hughes JA (2003) Cationic lipid vectors for plasmid DNA delivery. Curr Med Chem 10:1185-1193.
18. Karanth H and Murthy RS (2007) pH-sensitive liposomes-principle and application in cancer therapy. J Pharm Pharmacol 59:469-483.
19. Kichler A, Leborgne C, Savage PB, and Danos O (2005) Cationic steroid antibiotics demonstrate DNA delivery properties. J Control Release 107:174-182.
20. Kulms D and Schwarz T (2006) NF-kappaB and cytokines. Vitam Horm 74:283-300.
21. Ma B, Zhang S, Jiang H, Zhao B, and Lv H (2007) Lipoplex morphologies and their influences on transfection efficiency in gene delivery. J Control Release 123:184-194.
22. Martin B, Sainlos M, Aissaoui A, Oudrhiri N, Hauchecorne M, Vigneron JP, Lehn JM, and Lehn P (2005) The design of cationic lipids for gene delivery. Curr Pharm Des 11:375-394.
23. Narang AS, Thoma L, Miller DD, and Mahato RI (2005) Cationic lipids with increased DNA binding affinity for nonviral gene transfer in dividing and non-dividing cells. Bioconjug Chem 16:156-168.
24. Obata Y, Suzuki D, and Takeoka S (2008) Evaluation of cationic assemblies constructed with amino acid based lipids for plasmid DNA delivery. Bioconjug Chem 19:1055-1063.
25. Price A, Limberis M, Gruneich JA, Wilson JM, and Diamond SL (2005) Targeting viral-mediated transduction to the lung airway epithelium with the antiinflammatory cationic lipid dexamethasone-spermine. Mol Ther 12:502-509.
26. Price AR, Limberis MP, Wilson JM, and Diamond SL (2007) Pulmonary delivery of adenovirus vector formulated with dexamethasone-spermine facilitates homologous vector re-administration. Gene Ther 14:1594-1604.
27. Rajesh M, Sen J, Srujan M, Mukherjee K, Sreedhar B, and Chaudhuri A (2007) Dramatic influence of the orientation of linker between hydrophilic and hydrophobic lipid moiety in liposomal gene delivery. J Am Chem Soc 129:11408-11420.
28. Remy JS, Sirlin C, Vierling P, and Behr JP (1994) Gene transfer with a series of lipophilic DNA-binding molecules. Bioconjug Chem 5:647-654.
29. Ross PC and Hui SW (1999) Lipoplex size is a major determinant of in vitro lipofection efficiency. Gene Ther 6:651-659.
30. Salunke DB, Hazra BG, Pore VS, Bhat MK, Nahar PB, and Deshpande MV (2004) New steroidal dimers with antifungal and antiproliferative activity. J Med Chem 47:1591-1594.
31. Salvati A, Ciani L, Ristori S, Martini G, Masi A, and Arcangeli A (2006) Physicochemical characterization and transfection efficacy of cationic liposomes containing the pEGFP plasmid. Biophys Chem 121:21-29.
32. Schnare M, Rollinghoff M, and Qureshi S (2006) Toll-like receptors: sentinels of host defence against bacterial infection. Int Arch Allergy Immunol 139:75-85.
33. Wang L, Koynova R, Parikh H, and MacDonald RC (2006) Transfection activity of binary mixtures of cationic o-substituted phosphatidylcholine derivatives: the hydrophobic core strongly modulates physical properties and DNA delivery efficacy. Biophys J 91:3692-3706.
34. Wang L and MacDonald RC (2004) New strategy for transfection: mixtures of medium-chain and long-chain cationic lipids synergistically enhance transfection. Gene Ther 11:1358-1362.
35. Wang L and MacDonald RC (2007) Synergistic effect between components of mixtures of cationic amphipaths in transfection of primary endothelial cells. Mol Pharm 4:615-623.